DE69013431D1 - Anthocyanidine zur Behandlung von Augenkrankheiten. - Google Patents

Anthocyanidine zur Behandlung von Augenkrankheiten.

Info

Publication number
DE69013431D1
DE69013431D1 DE69013431T DE69013431T DE69013431D1 DE 69013431 D1 DE69013431 D1 DE 69013431D1 DE 69013431 T DE69013431 T DE 69013431T DE 69013431 T DE69013431 T DE 69013431T DE 69013431 D1 DE69013431 D1 DE 69013431D1
Authority
DE
Germany
Prior art keywords
anthocyanidins
delphidin
pelargonidin
treatment
eye diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69013431T
Other languages
English (en)
Other versions
DE69013431T2 (de
Inventor
Maria Jose Magistretti
Marisa Conti
Giorgio Pifferi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
IDB Holding SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDB Holding SpA filed Critical IDB Holding SpA
Publication of DE69013431D1 publication Critical patent/DE69013431D1/de
Application granted granted Critical
Publication of DE69013431T2 publication Critical patent/DE69013431T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69013431T 1989-07-28 1990-07-26 Anthocyanidine zur Behandlung von Augenkrankheiten. Expired - Fee Related DE69013431T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917323A GB8917323D0 (en) 1989-07-28 1989-07-28 Methods and pharmaceutical compositions for the treatment of ophthalmic diseases

Publications (2)

Publication Number Publication Date
DE69013431D1 true DE69013431D1 (de) 1994-11-24
DE69013431T2 DE69013431T2 (de) 1995-02-23

Family

ID=10660801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69013431T Expired - Fee Related DE69013431T2 (de) 1989-07-28 1990-07-26 Anthocyanidine zur Behandlung von Augenkrankheiten.

Country Status (11)

Country Link
US (1) US5196449A (de)
EP (1) EP0410749B1 (de)
JP (1) JP2967523B2 (de)
KR (1) KR0149026B1 (de)
AT (1) ATE112960T1 (de)
DE (1) DE69013431T2 (de)
DK (1) DK0410749T3 (de)
GB (1) GB8917323D0 (de)
HK (1) HK124595A (de)
IT (1) IT1245717B (de)
PT (1) PT94848A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
JP3414446B2 (ja) * 1993-07-23 2003-06-09 財団法人相模中央化学研究所 ヒドロキシシリル基を末端に有するポリオキシエチレン化合物、四級塩を末端に有するブロック共重合体、および経皮吸収促進剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
AU5706800A (en) * 1999-07-02 2001-01-22 Meiji Seika Kaisha Ltd. Compositions for foods, process for producing the same and functional foods and drinks containing the same
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
JP4593474B2 (ja) 2003-10-30 2010-12-08 明治製菓株式会社 チロシナーゼ活性阻害剤及び顔面血流改善剤
JP4873904B2 (ja) * 2005-08-22 2012-02-08 国立大学法人弘前大学 眼血管血流障害改善剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
JP2013163669A (ja) * 2012-01-12 2013-08-22 Oriza Yuka Kk 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2378272A1 (fr) * 1977-01-25 1978-08-18 Ferodo Sa Dispositif dynamometrique de mesure de couple pour engin a fleche de levage a commande par verin
BE864450R (fr) * 1978-03-01 1978-07-03 Inverni Della Beffa Spa Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
JPS55111418A (en) * 1979-02-21 1980-08-28 Santen Pharmaceut Co Ltd Remedy for eye disease and its preparation
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
DE3670570D1 (de) * 1986-09-02 1990-05-31 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Also Published As

Publication number Publication date
GB8917323D0 (en) 1989-09-13
JP2967523B2 (ja) 1999-10-25
IT9020968A0 (it) 1990-07-18
EP0410749B1 (de) 1994-10-19
EP0410749A3 (en) 1993-02-03
IT9020968A1 (it) 1992-01-18
KR0149026B1 (ko) 1998-10-15
JPH0381220A (ja) 1991-04-05
DK0410749T3 (da) 1994-11-14
ATE112960T1 (de) 1994-11-15
IT1245717B (it) 1994-10-14
EP0410749A2 (de) 1991-01-30
HK124595A (en) 1995-08-11
DE69013431T2 (de) 1995-02-23
PT94848A (pt) 1991-04-18
KR910002442A (ko) 1991-02-25
US5196449A (en) 1993-03-23

Similar Documents

Publication Publication Date Title
DE1300150T1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
DE68902649D1 (de) Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen.
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE112960T1 (de) Anthocyanidine zur behandlung von augenkrankheiten.
DE69521536T2 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE3865368D1 (de) Thiophensulfonamide zur behandlung von glaukom.
DE69024053D1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
HU911272D0 (en) Process for the production of medical preparations containing hexetidine
RU94038765A (ru) Способ лечения десцеметоцеле
RU94024966A (ru) Средство для улучшения процессов микроциркуляции и коррекции иммуногемостатических нарушений при лечении глазных заболеваний
PT97878A (pt) Processo para a preparacao de uma composicao farmaceutica para uso oftalmico contendo hexetidina ou seus derivados ou sais
RU94040875A (ru) Способ хирургического лечения отслойки сетчатки с использованием тампонирующих веществ
RU99103787A (ru) Способ лечения у детей болезни шойермана-мау
KR890000089A (ko) 신장 질환 치료제
RU93021719A (ru) Способ лечения отслойки сетчатки

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INDENA S.P.A., MAILAND/MILANO, IT

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee